Genetic Technologies (Genetic Technologies) Price-to-Tangible-Book : 4.92 (As of Apr. 27, 2024)

View and export this data going back to 2002. Start your Free Trial

What is Genetic Technologies Price-to-Tangible-Book?

As of today (2024-04-27), Genetic Technologies's share price is $2.221. Genetic Technologies's Tangible Book per Share of Dec. 2023 for the quarter that ended in Dec. 2023 was $0.45. Hence, Genetic Technologies's Price to Tangible Book Ratio of today is 4.92.

The historical rank and industry rank for Genetic Technologies's Price-to-Tangible-Book or its related term are showing as below:

GENE' s Price-to-Tangible-Book Range Over the Past 10 Years
Min: 1.61 Med: 3.56 Max: 33.94
Current: 6

During the past 13 years, Genetic Technologies's highest Price to Tangible Book Ratio was 33.94. The lowest was 1.61. And the median was 3.56.

GENE's Price-to-Tangible-Book is ranked worse than
78.7% of 169 companies
in the Medical Diagnostics & Research industry
Industry Median: 2.4 vs GENE: 6.00

A closely related ratio is called PB Ratio. As of today, Genetic Technologies's share price is $2.221. Genetic Technologies's Book Value per Sharefor the quarter that ended in Dec. 2023 was $0.84. Hence, Genetic Technologies's P/B Ratio of today is 2.65.

Genetic Technologies Price-to-Tangible-Book Historical Data

The historical data trend for Genetic Technologies's Price-to-Tangible-Book can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Genetic Technologies Price-to-Tangible-Book Chart

Genetic Technologies Annual Data

Trend

Jun14

Jun15

Jun16

Jun17

Jun18

Jun19

Jun20

Jun21

Jun22

Jun23

Price-to-Tangible-Book

Get a 7-Day Free Trial

10.07

2.96

3.88

2.25

3.16

Genetic Technologies Quarterly Data
	Dec17	Jun18	Dec18	Jun19	Dec19	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23
Price-to-Tangible-Book	Get a 7-Day Free Trial															4.24	-	3.16	-	5.32

Competitive Comparison of Genetic Technologies's Price-to-Tangible-Book

For the Diagnostics & Research subindustry, Genetic Technologies's Price-to-Tangible-Book, along with its competitors' market caps and Price-to-Tangible-Book data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Genetic Technologies's Price-to-Tangible-Book Distribution in the Medical Diagnostics & Research Industry

For the Medical Diagnostics & Research industry and Healthcare sector, Genetic Technologies's Price-to-Tangible-Book distribution charts can be found below:

* The bar in red indicates where Genetic Technologies's Price-to-Tangible-Book falls into.

Genetic Technologies Price-to-Tangible-Book Calculation

Genetic Technologies's price-to-tangible-book ratio for today is calculated as:

Price to Tangible Book	=	Share Price	/	Tangible Book per Share (Q: Dec. 2023 )
	=	2.221	/	0.451
	=	4.92

It can also be calculated from the numbers for the whole company:

Price to Tangible Book	=	Market Cap	/	Tangible Equity
	=	Market Cap	/	(Total Stockholders Equity	-	Preferred Stock	-	Intangible Assets)

A closely related ratio is called PB Ratio. The difference between Price-to-Tangible-Book Ratio and PB Ratio is that book value other than intangibles are used in the calculation.

Be Aware

Some businesses have very light assets, such as software companies or insurance agencies. The Price-to-Book Ratio does not work well for these companies. Some companies even have negative equity, so the Price-to-Book Ratio cannot be applied to them.

Genetic Technologies Price-to-Tangible-Book Related Terms

Thank you for viewing the detailed overview of Genetic Technologies's Price-to-Tangible-Book provided by GuruFocus.com. Please click on the following links to see related term pages.

Genetic Technologies (Genetic Technologies) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Diagnostics & Research » Genetic Technologies Ltd (NAS:GENE) » Definitions » Price-to-Tangible-Book

Comparable Companies

Traded in Other Exchanges

DU8:Germany GTG:Australia

Address

60-66 Hanover Street, Fitzroy, Melbourne, VIC, AUS, 3065

Website

https://www.gtglabs.com

Genetic Technologies Ltd is an Australia-based molecular diagnostics company that offers predictive testing and assessment tools to help physicians proactively manage women's health. The company has developed BREVAGenplus which is a clinically validated risk assessment test for non-hereditary breast cancer. It also provides genetic testing services including medical testing, animal testing, forensic testing, and plant testing. The company markets BREVAGenplus to healthcare professionals in breast healthcare and imaging centers, as well as to obstetricians/ gynecologists (OBGYNs) and breast cancer risk assessment specialists. The majority of the company's revenue is generated from Australia and the United States. The group has two operating segments: EasyDNA and GeneType/Corporate.